WO2008051407A2 - Embossed cell analyte sensor and methods of manufacture - Google Patents
Embossed cell analyte sensor and methods of manufacture Download PDFInfo
- Publication number
- WO2008051407A2 WO2008051407A2 PCT/US2007/022100 US2007022100W WO2008051407A2 WO 2008051407 A2 WO2008051407 A2 WO 2008051407A2 US 2007022100 W US2007022100 W US 2007022100W WO 2008051407 A2 WO2008051407 A2 WO 2008051407A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substrate
- blood glucose
- channel
- glucose sensor
- electrode
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49004—Electrical device making including measuring or testing of device or component part
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49764—Method of mechanical manufacture with testing or indicating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Definitions
- the present invention relates to medical devices for monitoring analyte in a living body, such as monitoring glucose levels in people with diabetes. More particularly, the invention relates to an analyte sensor having an embossed sample chamber.
- a mesh, insulation and lidding tape arrangement is used in the first common method of test strip construction.
- a base electrode is first formed on a substrate.
- a surfactant-coated mesh is then adhered to the base electrode by an overprinted layer of insulation ink.
- the ink is applied in a printed pattern.
- the open (non-printed) area of the pattern forms the sample cell and defines the working area on the base electrode.
- a lidding tape is then adhered to the upper surface of the insulation printing leaving sufficient openings for the air to escape as the strip fills with blood during use.
- a disadvantage of this method is that print registration accuracy and ink rheology limits the smallest size of cell that can be manufactured repeatably. In addition, three separate processing steps are required, and the mesh and insulation materials are relatively expensive.
- a die-cut spacer and hydrophilic lidding tape are used. This method typically involves laminating a die-cut spacer to a hydrophilic lidding tape. The lidding tape is in turn laminated to a base electrode on a substrate.
- the adhesive used at all of the interfaces is pressure sensitive.
- a disadvantage of this second method is that gumming problems are often encountered when cutting pressure sensitive adhesives. Test strip manufacturing equipment is typically what gums up, but test strip ports on a user's meter can also be disabled by fouling caused by the adhesives. Additionally, mechanical punches can only be scaled down to a certain size. Also, in this process registration is critical in all planes, and the materials used are expensive.
- Spraying is another method of laying fine coatings of reagent onto moving webs but also suffers from some disadvantages.
- the center of the stripe In a reversal of the situation seen with slot coating, it is not uncommon for the center of the stripe to be thicker than the edges. This helps with sample chamber sealing, but is also not uniform. Since spraying is also a continuous process, it too is wasteful of reagent, and it is difficult to define areas accurately without masks. Even with tight controls on strip manufacture, there typically is variation across different strip lots.
- some type of strip calibration is usually employed. For example, a representative sample of strips from each lot can be tested after manufacture. A calibration code can be determined from the testing and this code can be provided with each strip in the associated lot, such as on a packaging label.
- the code Before use of each package of test strips, the code can be entered into the meter, thereby calibrating the meter with the particular strips being used to provide accurate test results. However, this requires the user to perform an extra step. Furthermore, if the user neglects to enter a new calibration code for a new package of strips or enters the code incorrectly, inaccurate test results may be obtained, potentially causing harm to the user. Some manufacturers have resorted to providing a machine readable code on each strip or strip packaging that can be read directly by the meter during use. While this may reduce errors, these systems are not foolproof and add cost to the test strips and meters.
- Another method of reducing calibration issues is to supply a sub-set of test strip production, having a given calibration code, to a given customer base having meters that are already calibrated for use with those particular test strips.
- the remainder of the test strip production is labeled with calibration codes and supplied to a different customer base having meters requiring manual entry of calibration codes.
- This method is only effective for the portion of customers that do not need to use the calibration codes.
- product supply problems can develop if the calibration distribution does not match the demand of both meter bases.
- an in vitro analyte monitoring system may be constructed to operate with a minimum of analyte fluid.
- a sensor may be formed by locating at least one electrode on a substrate, providing an embossed channel in the electrode, coating the channel with a reagent and covering the channel with a hydrophilic lidding tape.
- An opening to the channel may be provided at a distal end of the sensor so that when an analyte is applied to the opening, it is drawn into the channel by surface tension (i.e. wicking).
- a vent may be provided near an opposite end of the channel so that when the analyte fills the channel, air previously filling the channel can be evacuated through the vent.
- the embossing process may be performed either before or after the electrode(s) is applied to the substrate.
- electrodes may be applied to a non-conducting substrate before a channel is embossed.
- gold may be sputtering onto the substrate with a mask to form multiple electrodes separated by portions of the non-conducting substrate surface.
- an entire substrate surface may be sputtered with portions later being etched away to form spaces between multiple electrodes.
- a channel or channels may then be embossed into the electrode on the flat substrate.
- a channel or channels may be embossed into a sensor substrate before an electrode or electrodes are formed on the substrate.
- a much thinner coat of conductor can be used. This may be particularly advantageous when using expensive conductors such as gold.
- conductor materials that are more brittle can be considered for use with the pre-embossing approach.
- an embossing process used may be a rotary or a flat bed process.
- Various channel cross-sections may be employed, such as rectangular and V -shaped.
- embossed channels may have a semi-circular cross-section and may have a depth of less than about 200 microns. More preferably, the channels may be less than about 100 microns deep. Most preferably, channels may be less than about 50 microns deep.
- the active length of the test chamber channel may often be dictated by the layout of the test strip.
- an embossed channel is aligned with a longitudinal axis of a test strip. Other orientations may also be used.
- the active length of an embossed channel i.e. the length containing electrodes and reagent
- the active length may be less than about 10 mm. More preferably, the active length may be about 2 to 7mm, and most preferably the length may be about 3 to 4 mm.
- sample chamber volumes may be less than about 200 nanoliters, more preferably may be less than about 50 nanoliters, and most preferably may be less than about 20 nanoliters.
- reagent may be applied to the sample chamber channel through the use of a needle and squeegee, although other methods such as slot coating or spraying may also be used.
- Test strips are preferably manufactured in rows with the test strips attached side-by-side, and then singulated into individual test strips, such as by slitting or cutting, as one of the last manufacturing steps.
- one or more rows may form a moving web during manufacture.
- Reagent may be pumped through a needle or needles onto the moving web and a squeegee used to spread the reagent and wipe the excess from the web.
- test strips may be formed in individual sheets before being singulated, and the needle(s) and squeegee(s) may be moved relative to the sheets to apply and spread the reagent.
- Needle and squeegee deposition may take advantage of the volume of a channel already having been defined by an embossing step.
- the channel and surrounding area may have reagent deposited by the needle dosing system, which is then spread by the squeegee.
- the squeegee may collect and remove reagent from the flat areas surrounding the channel while leaving the channel fully filled.
- the wet reagent may then be dried to leave behind a thin film only in the channel.
- the final coat weight may typically be governed by reagent viscosity, squeegee hardness, squeegee pressure and reagent dilution.
- the delivery rate of the needle dosing system may be either perfectly balanced to the usage rate or may be in excess with a re-circulation or total loss system employed on the squeegee.
- a process for trimming the ends of the test strips may be provided to calibrate the sensors.
- the sensors After patterning electrodes, embossing, reagent coating and hydrophilic lid lamination as described above, the sensors may essentially be functional.
- a representative sample of sensors may be tested to ascertain at least one calibration parameter of the batch, such as a slope and/or intercept of a calibration curve.
- a range of slopes and/or other calibration parameters expected of the design may be found and a lower value may be selected for product release. By trimming the working area on the remaining electrodes the slope may then be adjusted to match this lower product release value.
- This trimming process can produce sensors that all have essentially the same calibration slope, thereby eliminating the need to mark the sensors with a calibration code and require that the code be entered into the test meter before use.
- the embossed test strip design embodiments described above are particularly well suited to such trimming due to their long channel lengths in relation to their cross sectional areas, and the fact that sensor registration need not be performed in more than one direction during the trimming process.
- analytes may be monitored using aspects of the present invention. These analytes may include but are not limited to lactate, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK- MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hematocrit, hemoglobin (e.g. HbA 1 c), hormones, ketones, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin, in samples of body fluid.
- lactate lactate
- acetyl choline amylase
- bilirubin cholesterol
- chorionic gonadotropin e.g., CK- MB
- creatine kinase
- DNA DNA
- fructosamine glucose
- glutamine growth hormones
- hematocrit hematocrit
- hemoglobin
- Meters may also be configured to determine the concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, warfarin and the like.
- antibiotics e.g., gentamicin, vancomycin, and the like
- Fig. 1 is a plan view showing a test strip sensor in use with a glucometer.
- Fig. 2 is an exploded perspective view showing components of an exemplary embodiment of a test strip sensor constructed according to aspects of the present invention
- Fig. 3 is a perspective view showing the components of Fig. 2 in an assembled configuration
- Fig. 4 is a perspective view showing an alternative embodiment sensor
- Fig. 5 is a side elevational view showing reagent being dispensed and distributed on a series of sensors according to aspects of the present invention
- Fig. 6 is a plan view depicting a trimming process according to aspects of the present invention.
- Fig. 1 shows a top view of an exemplary analyte system 10, a glucometer system in this particular embodiment.
- System 10 includes a handheld meter 12 and disposable test strip sensor 14.
- Test strip 14 can be inserted into and removed from test strip port 16 of meter 12 for physical and electrical interconnection therewith.
- Meter 12 includes a liquid crystal display 18 for displaying information to the meter user, and buttons 20, 22 and 24 for receiving input from the user.
- a user inserts a new test strip 14 into port 16 of meter 12. Either before or after strip insertion into the meter, a user lances a fingertip or other part of the body (i.e. an alternate site) to draw a small drop of blood 26 to the surface of the skin. The meter and strip are positioned over the drop of blood 26 so that one of the sample chamber ends 28 is touching the drop of blood 26. While this particular example teaches the use of a side- fill strip, it should be noted that an end-fill, top-fill or other type of test strip may be utilized, as will be later described. Moreover, the analyte testing need not use a test strip at all.
- a rotary test wheel having multiple sensors may be provided instead of individual test strips.
- surface tension wicking
- an electrochemical test is automatically performed by meter 12 to determine the glucose concentration in the blood 26.
- the glucose level 30 is then displayed on meter 12.
- sensor 32 includes a substrate 34, a cover strip 36 and lidding tape 38.
- a fill trigger electrode 40, a working electrode 42 and a reference electrode 44 can be patterned near a distal end 46 of substrate 34.
- Conductive electrodes 40, 42 and 44 may be separated by portions of non-conductive substrate 34, and may be linked by conductive traces to connector pads 48, 50 and 52, respectively.
- connector pads 48, 50 and 52 each may electrically connect with associated connector contacts (not shown) within meter 12 shown in Fig. 1. Fewer, additional or different electrode types may be used.
- fill electrode 40 may be omitted, and/or a second working electrode may be added to allow for hematocrit compensation.
- channel 54 is embossed into substrate 34 and traverses each of the electrodes 40, 42 and 44.
- a reagent is added to channel 54, an example of which is later described below.
- Lidding tape 38 may be applied to substrate 34, such as with a pressure sensitive adhesive to cover channel 54.
- Cover strip 36 may be added, such as with a pressure sensitive adhesive, mainly for aesthetic reasons and to protect the conductive traces. The above steps create a functional test strip, as shown in Fig. 3. Additional manufacturing steps may be performed, as will be later described.
- the above construction forms a sample test chamber, bounded on the bottom by channel 54 in substrate 34, and on the top by lidding tape 38.
- An open end 56 of the sample chamber located at or near the distal end 46 of test strip 32, allows sample fluid such as blood to enter the sample chamber.
- Lidding tape 38, its adhesive, and the materials forming substrate 34 and electrodes 40, 42 and 44 all are preferably hydrophilic. This arrangement allows the sample chamber to automatically fill with sample fluid by surface tension (wicking) when opening 56 is placed in contact with the fluid.
- the dimensions and tolerances of channel 54 and lidding tape 38 are selected to ensure that channel 54 extends towards the proximal end 58 of strip 32 farther than lidding tape 38 to create a vent 60.
- Vent 60 allows air displaced by the filling fluid to easily escape the sample chamber without impeding fluid flow.
- a gap 62 can be left between cover strip 36 and lidding tape 38 to help ensure that vent 60 is not blocked.
- cover strip 36 may be omitted altogether to reduce material and assembly costs and to keep vent 60 exposed.
- one of cover strip 36 and lidding tape 38 may overlap the other.
- cover strip 36 may overlap lidding tape 38 by about lmm. Since the edge of the lower layer being overlapped has some thickness which creates a step, the upper layer is unable to form a perfect seal against the step. This incomplete seal extends the vent laterally along the step out to each side of test strip 32.
- Embossed channel 54 may align with the longitudinal axis of strip 32 to create an end-fill strip, such as shown in Fig. 3.
- the channel may be perpendicular to the strip axis.
- An example of such a side-fill arrangement is shown in Fig. 1, with one sample chamber end 28 serving to fill the chamber with fluid in this embodiment, and the sample chamber end 28 on the opposite side of the strip 14 serving to evacuate escaping air.
- Other configurations for embossed channel 54 may also be used.
- Fig. 4 illustrates a variation of strip 32 shown in Fig. 3.
- the lidding tape 38' of strip 32' is shortened so that it does not extend to the end of strip 38'.
- channel 54 portions of channel 54 and substrate 34 are exposed to create a landing pad 64 for receiving blood or other analyte, thereby forming a top-fill strip.
- a drop of blood 26 can be placed on landing pad 64 adjacent to or on top of the outer edge of lidding tape 38', as shown in Fig. 4. Blood 26 is wicked into channel 54 between lidding tape 38' and substrate 34 and is tested as previously described.
- channel 54 may be embossed before or after electrodes 40, 42 and 44 are patterned on substrate 34.
- channel 54 When channel 54 is embossed after electrodes are patterned on substrate 34, materials and processes may be chosen to avoid excessive damage to the electrodes, such as straining the electrode material(s) so much that their resistances increase drastically or the materials actually break. Such problems may be avoided by using a ductile electrode material like gold or similar metals, and/or by increasing the thickness of the electrode material(s). Male and female embossing tools may also be designed to reduce excessive material flow, thereby alleviating the above problems. A thicker and/or softer substrate and a shallower channel are other factors that can lessen the damage to the electrodes. By adjusting the tools, materials, thicknesses and processes used for making channel 54, an acceptable balance between channel depth and electrode damage can be struck for a particular set of sensor requirements.
- a preferred substrate material may be PVC since it embosses readily.
- Another preferred material may be polyester. Polyester may not emboss as readily as PVC, but its use may facilitate faster reagent drying times. Polyester may be heated to 75 degrees Celsius without shrinkage, while PVC should not be heated above 55 degrees C. Polypropylene may be another preferred substrate material since it offers a compromise between the properties of PVC and Polyester.
- a test strip 32 having a very small sample volume and very repeatable geometric features may be produced.
- the small sample volume allows users to perform "alternate site testing" (i.e. at locations other than the fingertips) and allows less blood to be drawn. This in turn reduces or eliminates the pain involved with drawing blood, may reduces the mess of blood samples on the skin and causes less trauma to the body.
- sample sizes may be less than about 20 nanoliters.
- the repeatable geometric features that can be achieved by the test strips disclosed herein further increase the accuracy and precision of analyte testing with the strips.
- test strips 32 are formed side by side on a continuous web of substrate material 34, to be singulated into individual strips 32 during a later manufacturing process.
- substrate 34 may be patterned with electrode material 44 and other electrodes (not shown), and channels 54a - 54e may be embossed into the electrodes and/or substrate 34, as previously described above.
- the web of substrate material 34 may then be moved in the direction of Arrow A shown, under stationary reagent fill needle 66 and squeegee 68.
- Reagent 70 may be pumped, gravity fed or otherwise supplied through needle 66 onto moving substrate 34.
- Squeegee 68 can help spread reagent 40 across channels 54 and wipe excess reagent from the electrodes and substrate 34. Essentially all reagent 70 may be removed from the surface of substrate 34, leaving reagent 70 only in channels 54, which are then preferably full. Reagent 70 may be precisely metered onto substrate 34 to avoid wasting reagent 70. Alternatively, more reagent 70 than is needed may be supplied to substrate 34 to ensure complete coverage, and the excess may be recycled or discarded. Fig.
- FIG. 5 depicts a yet to be filled channel 54a, a channel 54b in the process of being filled with reagent 70 by needle 66 and leveled by squeegee 68, a channel 54c that has been filled and leveled, and two channels 54d and 54e that have been filled, leveled and now dried, leaving only a thin layer of reagent 70 along the channels.
- single or multiple reagent needles 66 and/or single or multiple squeegees 68 may be utilized. Multiple needles may provide the same or different reagents to substrate 34. Needle(s) 66 need not have a circular or oval opening, but rather may have an elongated slot or a different shaped orifice. Squeegee(s) 68 need not be separate from needle(s) 66, but may be incorporated therein. The above arrangements may be utilized in batch processes rather than with the roll stock depicted.
- substrate cards (not shown) containing a finite array of test strips 32 can be coated with reagent 70 and leveled by holding the cards stationary while moving needle(s) 66 and squeegee(s) 68 (either separately or in tandem) over the test strip cards.
- FIG. 6 an exemplary embodiment is shown for trimming test strips 32 according to aspects of the present invention. After test strips
- a representative sample may be tested.
- a sufficient number of test strips should be tested (or in other words a "batch size" should be small enough) so that it may be safely assumed that all test strips 32 in each particular batch if tested would yield substantially the same test results as the representative sample.
- the entire batch has certain calibration characteristics, such as having a calibration curve with a particular slope. Rather than labeling the batch with the calibration characteristic (e.g. slope) and calibrating a meter 12 to the strip 32 during use, strip 32 may be modified during manufacture to "calibrate" it to the meter 12. By decreasing the volume of covered channel 54 and the area of the working electrode 44, the slope of a strip's calibration curve can be reduced to a preset value.
- a relatively small portion of the distal end 46 of the test strip 32 may be removed. This can be accomplished by trimming a series of unsingulated test strips 32 along line B, such as by slitting or cutting, as shown in Fig. 6. The location of cutting line B may be varied depending on how much functional change to strips 32 is desired. A representative sample of the trimmed test strips 32 may again be tested to ensure that each batch now has essentially the same characteristics. After trimming (if needed), test strips 32 may be separated from each other. Alternatively, test strips 32 may be singulated first and then trimmed, if needed. The above- described testing and trimming procedures may be conducted before or after any aging process. With use of the above manufacturing method, the need for user calibration can be eliminated. Also, the comers of the distal ends 46 of strips 32 may be chamfered to match the edges of working electrodes 44 shown in Fig. 6 to increase user comfort and ease of use.
- a ductile electrode material may be chosen to avoid excessive damage to the electrode during an embossing step.
- the following discussion is intended to provide definition to the term "ductile".
- the material response for ductile and brittle materials are exhibited by both qualitative and quantitative differences in their respective stress-strain curves. Ductile materials withstand large strains before rupture; brittle materials fracture at much lower strains. The yielding region for ductile materials often takes up the majority of the stress-strain curve, whereas for brittle materials it is nearly nonexistent. Brittle materials often have relatively large Young's moduli and ultimate stresses in comparison to ductile materials.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0716334-7A BRPI0716334A2 (en) | 2006-10-24 | 2007-10-16 | "Starch Cell Analyte Sensor and Manufacturing Methods" |
CA002667356A CA2667356A1 (en) | 2006-10-24 | 2007-10-16 | Embossed cell analyte sensor and methods of manufacture |
JP2009534592A JP2010507805A (en) | 2006-10-24 | 2007-10-16 | Embossed cell specimen sensor and manufacturing method |
EP07852797A EP2078194A2 (en) | 2006-10-24 | 2007-10-16 | Embossed cell analyte sensor and methods of manufacture |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/552,234 | 2006-10-24 | ||
US11/552,234 US7312042B1 (en) | 2006-10-24 | 2006-10-24 | Embossed cell analyte sensor and methods of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008051407A2 true WO2008051407A2 (en) | 2008-05-02 |
WO2008051407A3 WO2008051407A3 (en) | 2008-12-31 |
Family
ID=38863268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/022100 WO2008051407A2 (en) | 2006-10-24 | 2007-10-16 | Embossed cell analyte sensor and methods of manufacture |
Country Status (8)
Country | Link |
---|---|
US (6) | US7312042B1 (en) |
EP (2) | EP2078194A2 (en) |
JP (2) | JP2010507805A (en) |
CN (1) | CN101563605A (en) |
BR (1) | BRPI0716334A2 (en) |
CA (1) | CA2667356A1 (en) |
RU (2) | RU2461002C2 (en) |
WO (1) | WO2008051407A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010032501A (en) * | 2008-06-24 | 2010-02-12 | Panasonic Corp | Biosensor, manufacturing method of same, and detection system with same |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
CA2448902C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
WO2005033659A2 (en) | 2003-09-29 | 2005-04-14 | Pelikan Technologies, Inc. | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8057404B2 (en) * | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
US7312042B1 (en) * | 2006-10-24 | 2007-12-25 | Abbott Diabetes Care, Inc. | Embossed cell analyte sensor and methods of manufacture |
CN103323610B (en) | 2007-10-02 | 2016-12-28 | 赛拉诺斯股份有限公司 | Modular point-of-care devices and application thereof |
ES2626637T3 (en) * | 2008-01-18 | 2017-07-25 | Lifescan Scotland Limited | Method of manufacturing batches of test strips that have a predetermined calibration characteristic |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US8262874B2 (en) * | 2008-04-14 | 2012-09-11 | Abbott Diabetes Care Inc. | Biosensor coating composition and methods thereof |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8366485B2 (en) | 2009-03-19 | 2013-02-05 | Fci Americas Technology Llc | Electrical connector having ribbed ground plate |
US8608937B2 (en) * | 2009-03-30 | 2013-12-17 | Roche Diagnostics Operations, Inc. | Biosensor with predetermined dose response curve and method of manufacturing |
WO2010138817A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP5698085B2 (en) | 2010-07-12 | 2015-04-08 | アークレイ株式会社 | Biosensor and manufacturing method thereof |
CN102478573A (en) * | 2010-11-29 | 2012-05-30 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for evaluating validity of gentamycin test strip in dairy product detection |
CN106323876B (en) | 2011-01-21 | 2020-02-14 | 西拉诺斯知识产权有限责任公司 | System and method for maximizing sample usage |
US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US9700253B2 (en) | 2012-03-16 | 2017-07-11 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US9557288B2 (en) | 2013-04-29 | 2017-01-31 | Hewlett-Packard Development Company, L.P. | Electrochemical sensing well |
US9500616B2 (en) * | 2013-12-23 | 2016-11-22 | Cilag Gmbh International | Multi-orientation test strip |
US9841391B2 (en) * | 2014-09-09 | 2017-12-12 | LifeSan Scotland Limited | Hand-held test meter with integrated thermal channel |
US10197522B2 (en) | 2015-03-18 | 2019-02-05 | Materion Corporation | Multilayer constructs for metabolite strips providing inert surface and mechanical advantage |
US10378098B2 (en) | 2015-03-18 | 2019-08-13 | Materion Corporation | Methods for optimized production of multilayer metal/transparent conducting oxide (TCO) constructs |
CN105319254B (en) * | 2015-11-26 | 2017-04-19 | 济南大学 | Preparation and application of electrochemical immunosensor based on Pt/PdCu-three-dimensional graphene markers |
JP2019529935A (en) * | 2016-10-05 | 2019-10-17 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Detection reagents and electrode arrangements for multi-sample diagnostic test elements and methods of using them |
US10334515B2 (en) | 2017-01-13 | 2019-06-25 | ENK Wireless, Inc. | Conveying information via auxiliary device selection |
EP3406193B1 (en) * | 2017-05-23 | 2021-12-08 | Roche Diabetes Care GmbH | Sensor system and method for manufacturing thereof |
CN110944689B (en) | 2017-06-07 | 2022-12-09 | 施菲姆德控股有限责任公司 | Intravascular fluid movement devices, systems, and methods of use |
JP2019078573A (en) * | 2017-10-20 | 2019-05-23 | アークレイ株式会社 | Biosensor manufacturing method |
CN111556763B (en) | 2017-11-13 | 2023-09-01 | 施菲姆德控股有限责任公司 | Intravascular fluid movement device and system |
JP7410034B2 (en) | 2018-02-01 | 2024-01-09 | シファメド・ホールディングス・エルエルシー | Intravascular blood pump and methods of use and manufacture |
US20220032259A1 (en) * | 2018-09-12 | 2022-02-03 | Ohio State Innovation Foundation | Chemical actuators |
US20200129105A1 (en) * | 2018-10-29 | 2020-04-30 | Medtronic Minimed, Inc. | Physiological characteristic sensors and methods for making and operating such sensors |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
US20220057358A1 (en) * | 2020-08-20 | 2022-02-24 | Polymer Technology Systems, Inc. | Systems and Methods for a Test Strip Calibrator Simulating an Electrochemical Test Strip |
CN112101830B (en) * | 2020-11-23 | 2021-04-23 | 广州万孚健康科技有限公司 | Preparation and calibration method and system of test strip for detecting HIV antibody and storage medium |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7058437B2 (en) | 1998-10-08 | 2006-06-06 | Therasense, Inc. | Methods of determining concentration of glucose |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62180263A (en) * | 1986-02-04 | 1987-08-07 | Terumo Corp | Oxygen sensor |
US4988630A (en) * | 1987-04-27 | 1991-01-29 | Hoffmann-La Roche Inc. | Multiple beam laser instrument for measuring agglutination reactions |
JPH041337A (en) | 1990-04-19 | 1992-01-06 | Matsushita Electric Works Ltd | Warm water cleaner |
DE19541619A1 (en) * | 1995-11-08 | 1997-05-15 | Bosch Gmbh Robert | Electrochemical sensor and method for producing an electrochemical sensor |
JPH09201337A (en) * | 1996-01-25 | 1997-08-05 | Casio Comput Co Ltd | Glucose measuring device |
ATE227844T1 (en) * | 1997-02-06 | 2002-11-15 | Therasense Inc | SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
JP3874321B2 (en) * | 1998-06-11 | 2007-01-31 | 松下電器産業株式会社 | Biosensor |
KR100340174B1 (en) * | 1999-04-06 | 2002-06-12 | 이동준 | Electrochemical Biosensor Test Strip, Fabrication Method Thereof and Electrochemical Biosensor |
MXPA02009666A (en) * | 2000-03-28 | 2004-07-30 | Inverness Medical Technology I | Continuous process for manufacture of disposable electro-chemical sensor. |
AU2001262982A1 (en) * | 2000-05-08 | 2001-11-20 | Mass Sensors, Inc. | Microscale mass spectrometric chemical-gas sensor |
US6994827B2 (en) * | 2000-06-03 | 2006-02-07 | Symyx Technologies, Inc. | Parallel semicontinuous or continuous reactors |
JP4623870B2 (en) * | 2001-06-28 | 2011-02-02 | パナソニック株式会社 | Biosensor and method for adjusting measurement sensitivity thereof |
US6766817B2 (en) | 2001-07-25 | 2004-07-27 | Tubarc Technologies, Llc | Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action |
US6939450B2 (en) * | 2002-10-08 | 2005-09-06 | Abbott Laboratories | Device having a flow channel |
DK1578612T3 (en) * | 2002-10-30 | 2007-06-11 | Lifescan Scotland Ltd | Process with an endless path for producing electrochemical sensors |
US20040118704A1 (en) * | 2002-12-19 | 2004-06-24 | Yi Wang | Analyte test intrument having improved versatility |
JP2004226358A (en) * | 2003-01-27 | 2004-08-12 | Matsushita Electric Ind Co Ltd | Biosensor |
GB0306163D0 (en) * | 2003-03-18 | 2003-04-23 | Univ Cambridge Tech | Embossing microfluidic sensors |
US8153081B2 (en) * | 2003-05-29 | 2012-04-10 | Bayer Healthcare Llc | Test sensor and method for manufacturing the same |
US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US8071030B2 (en) * | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
JP2007524816A (en) | 2003-06-20 | 2007-08-30 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Method for producing thin uniform reagent strip and its reagent |
RU2007114896A (en) * | 2004-09-20 | 2008-10-27 | БАЙЕР ХЕЛТКЭА ЭлЭлСи (US) | OPTICAL SENSOR AND METHODS OF ITS MANUFACTURE |
US7418285B2 (en) * | 2004-12-29 | 2008-08-26 | Abbott Laboratories | Analyte test sensor and method of manufacturing the same |
US7312042B1 (en) * | 2006-10-24 | 2007-12-25 | Abbott Diabetes Care, Inc. | Embossed cell analyte sensor and methods of manufacture |
NL2003126C2 (en) * | 2009-07-03 | 2014-05-08 | Micronit Microfluidics Bv | Method for manufacturing and testing microfluidic chips. |
-
2006
- 2006-10-24 US US11/552,234 patent/US7312042B1/en active Active
-
2007
- 2007-10-16 BR BRPI0716334-7A patent/BRPI0716334A2/en not_active Application Discontinuation
- 2007-10-16 WO PCT/US2007/022100 patent/WO2008051407A2/en active Application Filing
- 2007-10-16 EP EP07852797A patent/EP2078194A2/en not_active Withdrawn
- 2007-10-16 EP EP14158594.3A patent/EP2759833B1/en not_active Not-in-force
- 2007-10-16 CN CNA200780044498XA patent/CN101563605A/en active Pending
- 2007-10-16 JP JP2009534592A patent/JP2010507805A/en not_active Withdrawn
- 2007-10-16 RU RU2009115484/15A patent/RU2461002C2/en not_active IP Right Cessation
- 2007-10-16 CA CA002667356A patent/CA2667356A1/en not_active Abandoned
- 2007-11-05 US US11/935,176 patent/US7771926B2/en active Active
-
2010
- 2010-06-14 US US12/815,170 patent/US8211632B2/en not_active Expired - Fee Related
-
2012
- 2012-05-17 RU RU2012120483A patent/RU2625769C2/en not_active IP Right Cessation
- 2012-06-05 US US13/489,161 patent/US8632965B2/en active Active
- 2012-06-18 JP JP2012136576A patent/JP5344728B2/en not_active Expired - Fee Related
-
2014
- 2014-01-14 US US14/155,129 patent/US9638698B2/en not_active Expired - Fee Related
-
2017
- 2017-04-28 US US15/581,738 patent/US20170276685A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7058437B2 (en) | 1998-10-08 | 2006-06-06 | Therasense, Inc. | Methods of determining concentration of glucose |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
JP2010032501A (en) * | 2008-06-24 | 2010-02-12 | Panasonic Corp | Biosensor, manufacturing method of same, and detection system with same |
US9046479B2 (en) | 2008-06-24 | 2015-06-02 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor, method of producing the same and detection system comprising the same |
Also Published As
Publication number | Publication date |
---|---|
US20130031772A1 (en) | 2013-02-07 |
US8211632B2 (en) | 2012-07-03 |
CA2667356A1 (en) | 2008-05-02 |
CN101563605A (en) | 2009-10-21 |
JP5344728B2 (en) | 2013-11-20 |
US7312042B1 (en) | 2007-12-25 |
US7771926B2 (en) | 2010-08-10 |
US9638698B2 (en) | 2017-05-02 |
JP2012211916A (en) | 2012-11-01 |
US8632965B2 (en) | 2014-01-21 |
BRPI0716334A2 (en) | 2015-05-19 |
RU2461002C2 (en) | 2012-09-10 |
RU2009115484A (en) | 2010-10-27 |
EP2759833A1 (en) | 2014-07-30 |
JP2010507805A (en) | 2010-03-11 |
WO2008051407A3 (en) | 2008-12-31 |
EP2759833B1 (en) | 2016-06-08 |
RU2012120483A (en) | 2013-11-27 |
EP2078194A2 (en) | 2009-07-15 |
US20110099786A1 (en) | 2011-05-05 |
US20140127821A1 (en) | 2014-05-08 |
US20170276685A1 (en) | 2017-09-28 |
RU2625769C2 (en) | 2017-07-18 |
US20080101983A1 (en) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9638698B2 (en) | Embossed cell analyte sensor and methods of manufacture | |
US9267911B2 (en) | Encoded biosensors and methods of manufacture and use thereof | |
US20080267823A1 (en) | Identification Of A Strip Type By The Meter Using Conductive Patterns On The Strip | |
EP1261868B1 (en) | Measurement of substances in liquids | |
CN101517402B (en) | Analyte sensors and methods | |
US8298389B2 (en) | In vitro analyte sensor, and methods | |
US8460524B2 (en) | System and methods of chemistry patterning for a multiple well biosensor | |
EP2076168B2 (en) | System and methods for determining an analyte concentration incorporating a hematocrit correction | |
JP2010525371A (en) | Uncalibrated analyte sensor and method | |
EP2594939A1 (en) | Biosensor with predetermined dose response curve and method of manufacturing | |
KR20170084310A (en) | Test element for electrochemically detecting at least one analyte | |
CN111278360B (en) | Sensor for detecting analytes in body fluids and method for manufacturing a sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780044498.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07852797 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2009115484 Country of ref document: RU Kind code of ref document: A Ref document number: 2009534592 Country of ref document: JP Kind code of ref document: A Ref document number: 2667356 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2703/DELNP/2009 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007852797 Country of ref document: EP |